← All companies

IART

Integra LifeSciences Holdings Corporation

IART Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$17.83

-0.07 -0.42%

Key statistics

from XBRL data in SEC filings

Market cap

$1.39B

Revenue (TTM)

$1.65B

Net income (TTM)

-$7.57M

EPS (TTM)

$-0.10

P/E ratio

—

Dividend yield

—

Free cash flow

-$31.1M

Cash

$214M

Total assets

$3.56B

Gross margin

51.7%

52-week range

$8.70 – $20.49

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Director or officer change; Shareholder vote results May 8, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Director or officer change May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Entered a material agreement Apr 15, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Director or officer change Dec 12, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release) Jul 31, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jun 9, 2025 8-K Director or officer change; Shareholder vote results; Other events May 13, 2025 10-Q Quarter ended 2025-03-31 May 5, 2025 8-K Results of operations (earnings release) May 5, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Other events Jan 6, 2025 8-K Director or officer change Dec 17, 2024 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release) Nov 4, 2024 8-K Director or officer change; Regulation FD disclosure Nov 4, 2024 10-Q Quarter ended 2024-06-30 Jul 29, 2024 8-K Results of operations (earnings release) Jul 29, 2024 8-K Other events May 17, 2024 8-K Director or officer change; Shareholder vote results; Other events May 13, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 8-K Results of operations (earnings release) May 6, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Director or officer change; Regulation FD disclosure Feb 28, 2024 8-K Results of operations (earnings release) Feb 28, 2024 8-K/A Director or officer change Feb 27, 2024 8-K Entered a material agreement Dec 20, 2023 8-K Director or officer change Dec 13, 2023 8-K Entered a material agreement; Regulation FD disclosure Dec 13, 2023 10-Q Quarter ended 2023-09-30 Oct 25, 2023 8-K Results of operations (earnings release) Oct 25, 2023